Introduction
Over the past several decades, intimate partner violence (IPV) has increasingly been recognized as a substantial cause of mortality and morbidity 1 . IPV is prevalent among diverse populations, affecting both men and women regardless of their socioeconomic status, sexual orientation, age, and ethnicity [2] [3] [4] . The myriad of long-term physical and emotional consequences of present and past IPV are well established [4] [5] [6] . Several studies have found that IPV is severely underreported among both male and female patient populations 2, 4, 7 . A recent study assessing the prevalence of IPV among women presenting to fracture clinics in two Level-1 trauma centers found that the overall prevalence of IPV (emotional, physical, and sexual abuse) within the previous twelve months was 32% 8 . The high prevalence of IPV among health-care users demonstrates the need for improved approaches for identifying patients in order to provide them with the opportunity for referral.
One method of identifying victims of IPV is through systematic screening programs implemented across health-care settings. Screening programs seek to encourage victims to feel comfortable speaking about their experience with IPV, as this disclosure is rarely spontaneous 9 . The multitude of physical and psychological outcomes associated with IPV frequently lead to victims' increased use of health-care services, including emergency, primary, and specialty care services 10 . These visits offer several opportunities for identification of IPV victims. One systematic review of twenty studies focusing on the effectiveness and acceptability of screening women for IPV in medical settings revealed that screening programs directly increased the rate of identification of victims and that most women had no objections to being screened 11 . Various medical fields including obstetrics, gynecology and family practice have successfully introduced screening programs for IPV 12 . The American College of Surgeons has stated that surgeons have a responsibility to identify IPV victims and help them to reduce or prevent further harm 13 . In 2009, the Canadian Orthopaedic Association (COA) stated that it is "good medical practice" for health-care providers to actively identify and offer assistance to victims of IPV 9 . To our knowledge, no previous studies have sought to identify whether patients in fracture clinics are open to being screened for IPV. The purpose of the present study was to explore patients' opinions and preferences regarding IPV screening programs in orthopaedic fracture clinics.
Materials and Methods

Study Design
We conducted a cross-sectional study to evaluate patients' perceptions and opinions on screening for IPV in the fracture clinic setting. The primary objective of the study was to determine whether patients in the fracture clinic thought it was acceptable for orthopaedic surgeons, orthopaedic nurses, and/or social workers in the fracture clinic to screen for IPV. Secondary key objectives included identifying (1) patients' preferences regarding the location, timing, mode, and duration of screening; (2) the type, age, sex, and race of the health-care provider by whom patients would feel most comfortable being screened; (3) differences between the attitudes and opinions held by men and women regarding IPV screening; and (4) differences in the reported preferences and opinions among the study sites. Four clinical sites in Ontario, Canada and one clinical site in the Netherlands participated in the study. Research Ethics Board approval was obtained from the McMaster University/Hamilton Health Sciences Research Ethics Board and from the Research Ethics Boards at each participating site.
Participants
Male and female patients who presented to the participating orthopaedic fracture clinics were screened for eligibility. Patients may have presented for immediate treatment of an injury, for follow-up of an injury, or for a chronic problem. In order to be considered for inclusion in the study, patients had to (1) present to the orthopaedic fracture clinic for their own appointment; (2) be at least sixteen years of age; (3) be able to read, understand, and write in English (in Canada) or Dutch (in the Netherlands); and (4) be able to separate themselves from anyone who accompanied them to the clinic, in order to ensure that they could complete the questionnaire in privacy. Patients were excluded if they were too ill or injured to participate or if they were cognitively impaired. Once patients were deemed eligible, informed consent was obtained and they were provided with the self-reported written questionnaire, which was completed anonymously. Participants were also provided with an IPV resource sheet for the local area if they were interested.
Study Questionnaire
The questionnaire comprised forty-five questions and was developed for the purposes of this study. The questionnaire provided patients with a definition of IPV and included questions on patient demographics, attitudes toward IPV in general, acceptability of IPV screening in an orthopaedic fracture clinic setting, and opinions on how, when, and by whom IPV screening in the orthopaedic fracture clinic should be conducted. The questionnaire was reviewed by content experts for face validity and piloted by a small subset of orthopaedic surgeons to ensure that the questions were unambiguous and appropriately targeted the domains of interest.
Study Sample Size
To ensure a ±5% margin of error around our estimates under the assumption of a total clinic population size of 20,000 and an anticipated 50% endorsement of screening across all centers over the recruitment period, we projected the need for at least 370 eligible and included study participants (http://www.raosoft.com/samplesize.html). To limit the risk of under powering of the study, we approximately doubled this value. The resulting sample size of 750 patients (150 from each of the participating study sites) was larger than those in previously published surveys on IPV screening [14] [15] [16] and was sufficient to provide meaningful results.
Data Analysis
Completed questionnaires were entered into a study-specific database, and descriptive statistics (including frequency counts and percentages) were calculated for all collected data. Continuous data are presented as the mean and the standard deviations. Chi-square tests were performed to determine whether any significant differences existed 164 among the clinical sites. Chi-square tests were also performed to determine whether any differences existed between the attitudes and preferences of men and women regarding IPV screening. For the series of questions inquiring about patient opinions, descriptive statistics were used to analyze the frequency of each answer.
The responses to each of the twenty questions related to the patient's openness to being screening for IPV were coded on a scale of one (least open) to five (most open), and the scores for the twenty questions were added to obtain an overall score (possible range, 20 to 100) for each participant. A stepwise regression analysis was performed to determine whether the following demographic characteristics related to a patient's openness to being screened for IPV: age (as a continuous variable), sex, income level, education level (up to high school compared with post-secondary), marital status, the length of the relationship, country (a Canadian compared with a Dutch clinical site), and whether or not the patient had children.
Patients who completed part of the questionnaire were included in the analysis; no statistical exploration process was carried out for the missing information. All data analyses were performed with the use of SPSS software (version 20.0; IBM, Armonk, New York).
Results
Recruitment (Figure 1)
Each participating site enrolled 150 eligible, consenting patients, resulting in a total of 750 patients included in the overall study cohort. Three of the five participating sites collected data on recruitment, including the number of patients excluded and reasons for exclusion. A total of 238 patients at these three sites were excluded from the study. 
Patient Demographics
The majority of participants in the study were white (81%; 610 of 750), and the mean age (and standard deviation) of the participants was 45 ± 17 years ( Table 1) . Just over one-half (56%) of the participants were male. Reasons for reporting to the fracture clinic included treatment of a fracture (40%), a sprain or strain (10%), a soft-tissue problem (8%), and arthritis (7%).
Acceptability of Screening for IPV in the Fracture Clinic
The majority of respondents (74%) indicated that the fracture clinic was a good place for health-care providers to ask patients about their experiences with IPV ( Table 2) . Nearly all respondents (94%) either agreed or strongly agreed that orthopaedic surgeons should look for the cause of a patient's injury, and 61% agreed that orthopaedic surgeons could help with IPV. The role of nurses and social workers in supporting victims of IPV within the fracture clinic setting was also endorsed. Nearly 80% of respondents agreed that it would be easier for victims of IPV to get help if health-care providers in the fracture clinic asked about abuse. Participant responses were similar across the five clinical sites. 
Patient Opinions on the Logistics of Screening
Nearly one-quarter of all respondents indicated that health-care providers in the fracture clinic should ask all women and all men about IPV (26% and 24%, respectively) ( Table 3 ). The majority of respondents thought that both women and men with suspicious injuries should be asked about IPV (73% and 68%, respectively). Talking face-to-face was the method of IPV screening endorsed by the vast majority of respondents (90%), followed by written questionnaires (22%). The overwhelming majority of respondents believed that screening should occur in a private location (91%) and that health-care providers should ask questions written by experts (72%).
Respondents also varied greatly in their opinions on what health-care providers in the fracture clinic should do when patients report that an intimate partner has abused them. The most common response involved asking the patients what they wanted to do (68%), followed by referral to hospital resources (60%) and to community resources (58%). Thirty-six percent indicated that the health-care provider should respond to such a situation by notifying the police. Less than 1% of respondents believed that the healthcare provider should do nothing when patients disclosed that they had been abused. Participant responses were similar across the five clinical sites. 
Comfort Level with Screeners
Seventy-three percent of the participants indicated that they would be comfortable discussing IPV with a social worker in the fracture clinic; 57%, with an orthopaedic surgeon; and 51%, with an orthopaedic nurse ( Table 2) . Few (8%) of the respondents reported they would be uncomfortable discussing IPV with any health-care provider in the fracture clinic. Respondents demonstrated a clear preference for having an older compared with a young health-care provider ask them about IPV (Figure 2) . Participant responses were similar across the five clinical sites.
General Opinions on IPV and IPV Screening According to Sex
There were significant differences between male and female participants' opinions on IPV and IPV screening ( Table 4) . For example, more female than male participants (74% compared with 55%) perceived IPV committed against men as a serious health issue (p < 0.001). Additionally, 57% of female respondents compared with 45% of male respondents disagreed or strongly disagreed with the statement that it would be embarrassing to be asked about IPV by a health-care provider (p = 0.004). There were no significant differences between male and female participants' opinion that IPV was a serious health in general. 
Openness to Screening
The stepwise regression analysis yielded a significant model (F 3595 = 21.950, p < 0.001). The following characteristics were associated with increased openness to screening: being female (p < 0.0001), having higher income (p < 0.0001), and having higher education (p = 0.035). These characteristics predicted 9.5% of the variation (adjusted r² = 0.095) on the twenty questions regarding patient's openness to being screened for IPV. Age, marital status, having children, being at a Canadian compared with a Dutch clinical site, and the length of relationship were not significant predictors in the model. The participants were generally very open to being screened, as the mean score for the twenty questions regarding openness to screening was 75.1 ± 9.4.
Discussion
The findings of this multicentre study suggest strong patient endorsement of IPV screening within the surgical fracture clinic setting. Patients indicated that surgeons, as the primary providers of care, should investigate the root cause of injuries. In response to questions 175 regarding which health-care provider should screen for IPV in the fracture clinic, patients indicated that a variety of health-care providers could have a critical role in detecting and managing cases of IPV. Although the responses suggested that patients felt social workers to be the most helpful in addressing the needs of IPV victims, the majority of participants felt that orthopaedic surgeons and nurses working in the fracture clinic could also help with IPV screening. Our findings imply that a team of multidisciplinary health-care providers in the fracture clinic setting could play a major role in identifying and helping IPV victims.
Approximately three-fourths of respondents questioned the need for universal screening of patients. Universal screening would involve health-care providers asking all patients (male and female) in their practice about their experiences with IPV (e.g., as a standard question in patient visits). In the current study, respondents also questioned the need for screening all female patients who present to the fracture clinic. Several previous studies have supported the implementation of universal screening programs for IPV (in contrast to incident-based or selected screening programs) 6, 14, [17] [18] [19] [20] . Rodriguez et al. 17 cited several reasons for universal screening for IPV, including the high prevalence, the array of acute and chronic health problems that are associated with IPV, the low level of suspicion and inquiry on the part of physicians, the general unwillingness of abuse victims to volunteer information, and the high level of patient acceptance of direct physician inquiry. In addition, multiple instances of IPV may be missed in incident-based or selected screening initiatives 21, 22 . Furthermore, clinician inquiry has been shown to be the most important determinant of a patient's disclosure of IPV to health-care providers 16, 17 . Our study suggests that patients may need additional education on the benefits of, and rationale for, a universal IPV screening program within the fracture clinic setting. It is imperative that health-care providers foster a relationship grounded in trust and openness with their patients in order to make sensitive discussions (such as ones focused on IPV) more comfortable and honest.
We found that patients preferred screening to be performed face-to-face with their healthcare provider and in a private location. Our findings on the preferred mode of screening directly contradict the findings of a 2006 randomized controlled trial that found face-to-face screening to be the least preferred approach among patients, with computerized and written methods being the most favored 23 . Most of the participants in the present study felt that, during screening, healthcare providers should ask questions written by experts and should ask about abuse directly. This indicates that patients would consider a standard screening tool and favor a direct method of screening. The ethnicity of the health-care provider screening for IPV was a less important factor to participants in the present study than the provider's age or sex was. These preferences should be taken into account when developing a successful screening program in a health-care setting, as patients who are comfortable discussing IPV with their health-care provider may be more open to disclosing whether they have been or are being abused.
There were significant differences between the attitudes of men and women regarding general questions about IPV and IPV screening. This was evident in questions regarding whether IPV against men was a serious health issue, whether health-care providers who ask women about IPV should ask men as well, and whether it would be embarrassing to be asked about IPV by a health-care provider. These discrepancies could be explained by the widespread notion in our society that men are perceived as physically superior to women and may be ridiculed if they disclose abuse 2. However, despite the differences in responses between the sexes, the majority of all respondents indicated that they would not be embarrassed or offended if asked about IPV by a health-care provider. This finding serves as direct evidence against the misperception outlined in 176 Bhandari et al. 24 , who reported that 19% of the surgeons surveyed believed that patients would get angry if asked about IPV. Multiple studies investigating patient opinions on IPV screening in other medical specialties have also revealed that most patients did not mind being asked about IPV and would be glad if someone showed interest in helping 16, 25, 26 . A slightly greater proportion (26.8%) of men in our sample strongly agreed or agreed that being asked about IPV would be embarrassing. This suggests that health-care providers should take a different approach with male patients than with female patients when broaching the topic of IPV.
Strengths and Limitations
Our results were strengthened by the use of trained female research coordinators to maximize enrollment and recruitment of both men and women sixteen years of age or older. The study cohort varied greatly in many characteristics, including age, sex, yearly household income, educational attainment, marital status, the length of the current relationship, and the injury or condition that was being treated at the fracture clinic. This diverse collection of participants is highly representative of individuals who may experience IPV at some point in their lifetime, increasing the external validity of our findings. Our inclusion of male fracture clinic patients offers a unique perspective on the issue of IPV screening. The majority of studies that have examined patients' preferences and opinions regarding IPV have only evaluated female patients' perspectives.
Because participants completed the survey independently (without their accompanying friend, family member, or partner present) and anonymously, we believe that the responses are an accurate depiction of the opinions and values of fracture clinic patients in general.
There are a few limitations to this study. First, only English-speaking patients were included from the Canadian sites and only Dutch and English speakers were included from the site in the Netherlands. This exclusion of patients on the basis of language may have resulted in selection bias. Culture may influence attitudes on IPV and IPV screening, and consideration of the perceptions of non-English-speaking individuals might have added to this study. Selection bias may have also been introduced by the exclusion of critically ill patients. Furthermore, the use of the self-completed questionnaire in a private location resulted in some missing data, which we were unable to retrieve later because the questionnaires were anonymous in design. Additionally, because of resources limitations, two of the participating sites were unable to collect information on patient screening. However, the data regarding screening and patient exclusion at these sites would presumably not be drastically different from the patterns exhibited at the other sites.
Our results demonstrate that fracture clinic patients were amenable to, and supported, active screening approaches for IPV. There is a need for increased awareness in the surgical community regarding IPV, with focused educational initiatives to prepare and engage surgeons to appropriately screen patients.
